This is a list of adverse effects of the anti-cancer drug nilotinib, sorted by frequency of occurrence.
Very common
Very common (>10% incidence) adverse effects include:
Common
Common (1–10% incidence) adverse effects include:
Uncommon
Uncommon (0.1–1% incidence) adverse effects include:
References




